Quantcast
Channel: OneMedPlace - Sentinel12735
Browsing all 2 articles
Browse latest View live

http://www.onemedplace.com/blog/wp-content/uploads/2009/04/test_tubes_flask.j...

Micromet has licensed one of its cancer-fighting antibody candidates to Sanofi-Aventis in a $477 million deal.

View Article



Antibody-Based Therapies, T-Cell Mediated Diseases.

Immunology, Oncology, Diabetes. Company provides a highly specific antibody-based T-cell antagonist with broad application potential in T-cell mediated conditions, including transplant rejection, type...

View Article
Browsing all 2 articles
Browse latest View live


Latest Images